Monoclonal antibody and biologic DMARD drug classes with their mechanism and one signature side effect per card, distinct from the innate and adaptive immune cell focus of the Immunology decks.
35 cards · basic cards · AI-written, checked twice. Edit anything.
- Infliximab: antibody class and target?
Show answer
Chimeric monoclonal antibody against TNF-alpha- Signature adverse effect of infliximab?
Show answer
Reactivation of latent tuberculosis- How does etanercept differ structurally from other anti-TNF drugs?
Show answer
It is a fusion protein of the TNF receptor and IgG Fc region, not a true monoclonal antibody- Adalimumab: antibody class and target?
Show answer
Fully human monoclonal antibody against TNF-alpha- Signature neurologic risk of anti-TNF therapy as a drug class?
Show answer
Increased risk of demyelinating disease resembling multiple sclerosis- Rituximab mechanism of action?
Show answer
Monoclonal antibody against CD20 that depletes B lymphocytes- Signature risk of rituximab therapy?
Show answer
Progressive multifocal leukoencephalopathy from JC virus reactivation- Trastuzumab target?
Show answer
HER2/neu receptor- Signature adverse effect of trastuzumab?
Show answer
Cardiotoxicity (reduced left ventricular ejection fraction)- Bevacizumab mechanism of action?
Show answer
Monoclonal antibody against VEGF that inhibits angiogenesis- Signature adverse effect of bevacizumab?
Show answer
Gastrointestinal perforation- Cetuximab target?
Show answer
Epidermal growth factor receptor (EGFR)- Signature adverse effect of cetuximab?
Show answer
Acneiform (papulopustular) rash- Natalizumab mechanism of action?
Show answer
Monoclonal antibody against alpha-4 integrin that blocks leukocyte migration across the blood brain barrier- Signature risk of natalizumab therapy?
Show answer
Progressive multifocal leukoencephalopathy from JC virus reactivation
FlashKeepers